Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database

(1) Background: The duration of adjuvant chemotherapy recommended by the NCCN guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy for many reasons; therefore, one approach is to obtain a survival benefit by prolonging the duration of capecitabine monotherapy. (2...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Qiao, Li, Zhigui, Liu, Yuqing, Luo, Yichen, Fan, Jingya, Xie, Peijun, Cao, Xiaoman, Chen, Xingyu, Wang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857854/
https://www.ncbi.nlm.nih.gov/pubmed/36661721
http://dx.doi.org/10.3390/curroncol30010072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857854/
https://www.ncbi.nlm.nih.gov/pubmed/36661721
http://dx.doi.org/10.3390/curroncol30010072

Ejemplares similares